Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Parkinson Disease
Condition: Monotherapy
Dose: Oral Tablet – 1 mg
Frequency: once daily
Indication: Parkinson Disease
Condition: Adjunct without levodopa
Dose: Oral Tablet – 1 mg
Frequency: once daily

Child Dose

Clinical InformationAdministration Information
Age: less than 18 years
Dose: Not established
Note: Safety and efficacy not established

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment: Mild-to-moderate
Dose: Not specified
Note: No dosage adjustment required
Condition: Renal impairment: Severe
Dose: Not specified
Note: Not studied in severe renal impairment
Administration
  • Can be taken with or without food
  • Take at same time each day
Side Effect

Drug Interaction

Drug NameRisk Factors
CYP1A2 inhibitors (e.g. ciprofloxacin)
Increased plasma levels
Entacapone
Increased clearance

Disease Interaction

Disease NameRisk Factors
Severe hepatic impairment
Can cause liver complications

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store below 30° c, protected from light and moisture. Keep all the medicines out of reach of children.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.